BERBERACTIV Trademark

Trademark Overview


On Friday, June 23, 2017, a trademark application was filed for BERBERACTIV with the United States Patent and Trademark Office. The USPTO has given the BERBERACTIV trademark a serial number of 87503670. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, May 27, 2025. This trademark is owned by Tesseract Medical Research, LLC. The BERBERACTIV trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing berberine; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of nutritional supplements for increasing berberine in the body for the treatment of elevated cholesterol levels, elevated blood sugar levels, and microbial imbalances in the gastrointestinal and respiratory tracts; functional nutrient preparations containing berberine to mitigate elevated cholesterol levels, elevated blood sugar levels, and microbial imbalances in the gastrointestinal and respiratory tracts; specialty nutraceut...
berberactiv

General Information


Serial Number87503670
Word MarkBERBERACTIV
Filing DateFriday, June 23, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, May 27, 2025
Registration Number5698167
Registration DateTuesday, March 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2018

Trademark Statements


Goods and ServicesDietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing berberine; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of nutritional supplements for increasing berberine in the body for the treatment of elevated cholesterol levels, elevated blood sugar levels, and microbial imbalances in the gastrointestinal and respiratory tracts; functional nutrient preparations containing berberine to mitigate elevated cholesterol levels, elevated blood sugar levels, and microbial imbalances in the gastrointestinal and respiratory tracts; specialty nutraceuticals for the dietary management of diseases, disorders, and adverse health conditions that can be remediated with berberine, namely, elevated cholesterol levels, elevated blood sugar levels, and microbial imbalances in the gastrointestinal and respiratory tracts

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 30, 2017
Primary Code005
First Use Anywhere DateFriday, June 15, 2018
First Use In Commerce DateFriday, June 15, 2018

Trademark Owner History


Party NameTesseract Medical Research, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653

Party NameTesseract Medical Research, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Party NameTesseract Medical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Trademark Events


Event DateEvent Description
Wednesday, March 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2017NEW APPLICATION ENTERED
Friday, June 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 21, 2017ASSIGNED TO EXAMINER
Friday, September 29, 2017NON-FINAL ACTION WRITTEN
Friday, September 29, 2017NON-FINAL ACTION E-MAILED
Friday, September 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 23, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, April 23, 2018EXAMINERS AMENDMENT E-MAILED
Monday, April 23, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 23, 2018EXAMINER'S AMENDMENT ENTERED
Friday, April 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 16, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 5, 2018PUBLISHED FOR OPPOSITION
Tuesday, June 5, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 31, 2018TEAS STATEMENT OF USE RECEIVED
Monday, December 31, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 31, 2018USE AMENDMENT FILED
Saturday, January 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, January 26, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, February 4, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 5, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 12, 2019REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2024TEAS SECTION 8 RECEIVED
Tuesday, March 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, May 5, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 6, 2025POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, May 27, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, May 27, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, May 12, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED